(Q43648475)

25 November 2017

Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn? (English)

1 reference

25 November 2017

1 reference

A C de Vries

1

1 reference

25 November 2017

E J Kuipers

series ordinal

2

1 reference

25 November 2017

E A J Rauws

series ordinal

3

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2009

1 reference

The American Journal of Gastroenterology

25 November 2017

1 reference

25 November 2017

104

1 reference

25 November 2017

6

1 reference

25 November 2017

1342-1345

1 reference

Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts

25 November 2017

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2008.15

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2008.15

Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2008.15

Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2008.15

Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2008.15

Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2008.15

Long-term sequelae of Helicobacter pylori gastritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2008.15

The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2008.15

Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2008.15

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2008.15

Long term follow up of patients treated for Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2008.15

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2008.15

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2008.15

Lack of eradication of Helicobacter pylori after omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2008.15

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2008.15

The risk of stomach cancer in patients with gastric or duodenal ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2008.15

Seroconversion for Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2008.15

21 January 2018

Identifiers

DOI

10.1038/AJG.2008.15

1 reference

25 November 2017

1 reference